Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Remedor Biomed

2009 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of a biomedical technology platform based on the combination of two naturally-occurring glycoproteints: erythropoietin (EPO) and fibronectin (FN). The company develops a formulation, based on erythropoietin and fibronectin, for therapeutical use in tissue regeneration in the processes of wound healing and bone repair.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Social/Platform Software
Primary Office
  • Ha-Avoda Street 12
  • Nazareth Iliit
  • Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Remedor Biomed’s full profile, request a free trial.

Remedor Biomed Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Remedor Biomed Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Next Generation Technology Venture Capital Minority 000 0000 000000 0

Remedor Biomed Executive Team (2)

Name Title Board
Seat
Contact
Info
Saher Remedor Ph.D Founder, Chief Technology Officer & Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »